Skip to main content

Table 1 Systemic parameters in the four intervention groups

From: Moderate intensity physical activity prevents increased blood glucose concentrations, fat pad deposition and cardiac action potential prolongation following diet-induced obesity in a juvenile-adolescent rat model

  CON PA HFHC HFHC + PA
Body weight (g) 444.8 ± 7.6 465.5 ± 8.9 441.1 ± 9.0 422.9 ± 8.0
Retroperitoneal (g) 7.8 ± 1.1 7.9 ± 0.6 12.6 ± 1.2* 9.0 ± 0.7
Subcutaneous (g) 8.3 ± 1.0 8.5 ± 0.7 10.1 ± 0.6 8.9 ± 1.3
Epididymal (g) 8.5 ± 1.0 6.2 ± 0.3 7.6 ± 0.7 7.8 ± 0.5
Mesenteric (g) 7.6 ± 0.9 8.5 ± 0.7 8.2 ± 0.5 7.4 ± 0.4
LV and septum (mg/g of bw) 2.2 ± 0.08 2.0 ± 0.08 2.1 ± 0.06 2.2 ± 0.08
RV (mg/g of bw) 0.5 ± 0.05 0.4 ± 0.03 0.5 ± 0.05 0.5 ± 0.02
Liver (mg/g of bw) 36.9 ± 0.7 36.8 ± 0.6 36.6 ± 0.9 37.5 ± 3.0
Spleen (mg/g of bw) 2.8 ± 0.1 2.7 ± 0.1 2.7 ± 0.1 2.9 ± 0.1
Kidneys (mg/g of bw) 7.6 ± 0.2 7.1 ± 0.1 8.2 ± 0.2* 8.5 ± 0.2*
4-HNE (mmol/L) 0.4 ± 0.2 10.4 ± 0.9* 3.6 ± 0.8*§ 12.2 ± 1.7*
IL-6 (pg/mL) 770.0 ± 91.9 194.3 ± 31.5* 620.0 ± 91.7 417.1 ± 35.6*
IL-1β (pg/mL) 105.4 ± 13.6 49.4 ± 8.8* 67.2 ± 12.0 52.9 ± 3.9*
Nitrate/Nitrite (μmol/L) 22.6 ± 1.2 33.6 ± 2.7 68.8 ± 5.2*†§ 34.5 ± 8.5
Glucose (mmol/L) 12.0 ± 1.1 11.9 ± 1.0 15.1 ± 0.6* 12.4 ± 1.0
  1. Data expressed as Mean ± SEM; n = 16 for all groups. CON, control; PA, physical activity treated; HFHC, high-fat, high-carbohydrate fed; HFHC + PA, high-fat, high-carbohydrate fed and physical activity treated. *P < 0.05 vs CON, P < 0.05 vs PA, P < 0.05 vs HFHC, §P < 0.05 vs HFHC + PA.